Pluri Stock (NASDAQ: PLUR) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 27.370K |
Day Range | - - - |
52 Wk Range | 3.449 - 8.560 |
Market Cap | $25.561M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 35 |
Short Interest | 2.07% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Pluri (NASDAQ: PLUR) through any online brokerage.
Other companies in Pluri’s space includes: Acurx Pharmaceuticals (NASDAQ:ACXP), T2 Biosystems (NASDAQ:TTOO), Lumos Pharma (NASDAQ:LUMO), Sensei Biotherapeutics (NASDAQ:SNSE) and Palatin Techs (AMEX:PTN).
There is no analysis for Pluri.
The stock price for Pluri (NASDAQ: PLUR) is $4.89 last updated April 19, 2024 at 9:27 AM EDT.
There are no upcoming dividends for Pluri.
Pluri’s Q3 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Pluri.
Pluri is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.